VLC Phage Hunters
@VLCphagehunters
We are VLCPhageHunters, a group of the #EnBiVirLab researchers specialised in the search for phages against multi-resistant bacteria! UV/CSIC (Valencia, Spain)
¿Habéis visto ya el vídeo que Diario de una Científica ha hecho sobre el trabajo que realizamos en el #EnBiVirLab y en @evolving_spain? 🤯🥰 ¡¡¡Nos encanta!!! instagram.com/reel/C0rwlvOqQ…
Learning from PhD projects of other colleagues from @i2sysbio at the 5th edition of the Early Career Researchers Seminar! 💪🏼😊 Very enriching!

Phage therapy in a patient with prosthetic join infection in Spain! Another sucessful treatment from the #EnBiVir @VLCphagehunters @evolving_spain in collaboration with Dr. de la Villa Special mention @mire_bg and @marcocv1497 for the phage production! sciencedirect.com/science/articl…
Today's pre-holiday lab meeting! Happy with the current progress and motivated to continue our research 😊💪🏼🙌🏼

Disfrutando de nuestro retreat de lab celebrando la plaza de profesora titular de @pilardomingoc 🥰🙌🏼


Otras alternativas terapéuticas como la fagoterapia en pacientes con enfermedad pulmonar por micobacterium abscessus. Gracias por vuestra ayuda! Muy agradecida 🙌🙌 #fagoterapia #mycobacteriumabscessus
Our PhD researcher Mireia @mire_bg presenting today at 1st International Symposium on Advances in Phage Therapeutics @AzeredoLab the preliminary results of 4 compassionate phage use for M. Abscessus infections using a 6-weeks treatment approach including local administration 💪🏼😊
Thrilled to have been awarded a Ramon y Cajal 5-year tenure-track contract to continue working on viral entry (and more!) with @Rafa_Sanjuan_ at @i2sysbio and @UV_EG 🎉😃
Late-decision abstract submissions are open for Phage Biology, Dynamics, and Therapeutics: iasusa.org/bacteriophage-…
Proud of our colleague from @Rafa_Sanjuan_’s lab @Jeremy_Dufloo who has been awarded a Ramon y Cajal contract from @CienciaGob 😊🙌🏼 well-deserved! 🥳 congrats! 💪🏼 @i2sysbio
Thrilled to have been awarded a Ramon y Cajal 5-year tenure-track contract to continue working on viral entry (and more!) with @Rafa_Sanjuan_ at @i2sysbio and @UV_EG 🎉😃
Coming back from enriching 2-days with all our scientific colleagues from the phage therapy field 😊 honored to share the first results of compassionate treatments for M. Abscessus as part of my PhD project 💪🏼 Thanks @pilardomingoc and @AzeredoLab for the opportunity!
Already available at @biorxivpreprint the results of one of the PhD projects from our colleague @LucasMQQQ 🥰 Valuable insights about K. pneumoniae phage-resistance mechanisms 🧫🙌🏼 Do not miss it! biorxiv.org/content/10.110… @pilardomingoc @Rafa_Sanjuan_
📢 Very excited to share our latest work on K. pneumoniae resistance to phages! We show that phage resistance can occur through capsule loss in a fast and reversible way in the abscence of mutations! 🦠🧬 biorxiv.org/content/10.110… @pilardomingoc @Rafa_Sanjuan_ Thread here!🧵👇🏻
Check out the full story 👉🏻 biorxiv.org/content/10.110… @VLCphagehunters #phage #Klebsiella #microbiology #capsule
These findings suggest that Klebsiella can resist phages via changes in gene expression, offering a flexible and dynamic alternative to mutation-driven resistance. A new layer of complexity in phage-bacteria interactions!💡🌌
Using single-cell assays, we found that once phage pressure was removed, these acapsular cells rapidly restored capsule production regaining sensitivity to phage. A fast and reversible response to phage selective pressure! 🦠🔁
In our study, phage infection selected for acapsular variants without any detectable mutations. However, we observed a significant downregulation of capsule related genes via transcriptomics. A non-mutational route to resistance! 🔬📊
Previous studies showed that Klebsiella evades phage infection by losing or modifying its capsule due to mutations in capsule biosynthesis genes 🧬
📢 Very excited to share our latest work on K. pneumoniae resistance to phages! We show that phage resistance can occur through capsule loss in a fast and reversible way in the abscence of mutations! 🦠🧬 biorxiv.org/content/10.110… @pilardomingoc @Rafa_Sanjuan_ Thread here!🧵👇🏻
Proud of @mire_bg presenting part of her PhD project treating M. abscessus-infected patients with #phage. Thanks to @AzeredoLab for the opportunity to present our work at the 1st Advances in Phage Therapeutics! @UV_EG @CSIC @VLCphagehunters @evolving_spain @FEFQ_CFspain
Our PhD researcher Mireia @mire_bg presenting today at 1st International Symposium on Advances in Phage Therapeutics @AzeredoLab the preliminary results of 4 compassionate phage use for M. Abscessus infections using a 6-weeks treatment approach including local administration 💪🏼😊
Our PhD researcher Mireia @mire_bg presenting today at 1st International Symposium on Advances in Phage Therapeutics @AzeredoLab the preliminary results of 4 compassionate phage use for M. Abscessus infections using a 6-weeks treatment approach including local administration 💪🏼😊


Mireia Bernabeu-Gimeno speaking in M. abscessus infections and phage therapy. Advances in #Phage Therapeutics
Visit our poster P06 at the 1st International Symposium on Advances in Phage Therapy #Braga2025 @AzeredoLab about mycobacteriophages!! Proud of @marcocv1497 presenting part of his PhD project!! @UV_EG @CSIC @VLCphagehunters
Come and visit our poster P06 during the poster sessions at 1st International Symposium on Advances in Phage Therapeutics @AzeredoLab 😊 Our colleague @marcocv1497 will be presenting our phage collection for M. Abscessus and all his work for expanding the host range!